Healthcare -
Biotechnology - NASDAQ - US
$ 1.29
-5.15 %
$ 76.7 M
Market Cap
-0.36
P/E
IGMS - COST OF REVENUE
Cost of Revenue IGMS - IGM Biosciences, Inc.
8.28 M
LAST VALUE
3.52%
2 YEAR CAGR
97.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR